Long-term use of statins can exacerbate the risk of developing Type 2 diabetes

Health Care Comments Off

Long-term use of statins can exacerbate the risk of developing Type 2 diabetes

Healthy diet and lifestyle changes can prevent complications

New Delhi, 10 December 2017:A recent study has indicated that those indulging in the long-term use of cholesterol-lowering drug, statin, are at 30% more at risk of developing Type-2 diabetes. It mentions that taking statin is associated with a 36% heightened risk of subsequently being diagnosed with Type-2 diabetes. Research also indicates that statins may impair the production of insulin, the hormone needed to lower the body’s levels of blood glucose.

Estimates place the number of people living with diabetes at 60 million in India, of which 95% have Type 2 diabetes. Type 2 diabetes is typically brought on by poor eating habits, too much weight and too little exercise. This condition, when poorly controlled, can increase the risk of cardiovascular disease, blindness, and even kidney failure.

Speaking about this, Padma Shri Awardee Dr K K Aggarwal, National President Indian Medical Association (IMA) and President Heart Care Foundation of India (HCFI) and Dr RN Tandon – Honorary Secretary General IMA in a joint statement, said, “In a person with Type 2 diabetes, the body does not utilize insulin properly and this condition is called as insulin resistance. The pancreas first makes extra insulin to make up for this. However, over time, it cannot make enough to keep the blood glucose at normal levels. While the exact trigger for this condition is not known, Type 2 diabetes could be a result of a combination of factors. Some may be genetically predisposed to the condition. People with a family history of obesity are also at an increased risk of developing insulin resistance and diabetes. Those who are obese have added pressure on their body’s ability to use insulin in controlling blood sugar levels. This can lead to Type 2 diabetes. The more fatty tissue a person has, the more resistant their cells become to insulin. Lifestyle factors also have a major role to play.”

The symptoms of Type 2 diabetes develop slowly, over a period of time. Some of them include increased thirst and hunger, frequent urination, weight loss, fatigue, blurred vision, slow healing of infections and wounds, and skin darkening in certain areas.

Adding further, Dr Aggarwal, said, “A healthy diet is, more expensive than an unhealthy one. The wide availability of cheap energy dense low-nutrient food is contributing to the global epidemic of type 2 diabetes. Foods which reduce the risk of type 2 diabetes such as vegetables, fresh fruit, whole grains and unsaturated fats need to be more affordable and more widely available.”

The following preventive measures can help prevent the onset of Type 2 diabetes in people.

  • Exercise more Exercise has various benefits including preventing weight gain, controlling blood sugar levels, and other conditions. A minimum of 30 minutes of physical activity every day is very beneficial.
  • Eat healthy A diet rich in whole grain, fruits, and vegetables is very good for the body. Fibrous food will ensure that you feel fuller for a longer period and prevent any cravings. Avoid processed and refined food as much as possible.
  • Limit your alcohol intake and quit smoking Too much alcohol leads to weight gain and can increase your blood pressure and triglyceride levels. Men should limit drinks to two per day and women to one per day. Smokers are twice as likely to develop diabetes as non-smokers and therefore, it is a good idea to quit this habit.
  • Understand your risk factors Doing so can help you in taking preventive measures at the earliest and avoid complications.

Straight from the Heart: CC Reporting

Health Care Comments Off

We have tried to compile the important meetings held during the year. Following is a list of meetings with government including stakeholders as well as international meetings that IMA participated in. All states branches can attempt to compile a similar list of meetings that your state participated in.Meetings with government/stakeholder’s/

officials

  • Inter-ministerial meetings
  • Monthly meeting of IMA with MoH
  • Shri JP Nadda on 20th January 2017
  • Shri CK Mishra on 3rd March 2017
  • Member of Parliament Doctors meeting on 17th May 2017
  • Addl. Secretary (Health) Shri Sanjeeva Kumar with IMA 19th May 2017
  • Shri Satyender Jain, Health Minster, Delhi Govt.
  • Shri JP Nadda on 6th June 2017
  • Dr Jagdish Prasad on 6th June 2017
  • Shri CK Mishra on 6th June 2017
  • Shri Jitendra Singh on 6th June 2017
  • Shri JP Nadda on 23rd June 2017
  • Dr CP Thakur, Dr Mahesh Sharma, Dr Sanjay Jaiswal and Dr Vikas Mahatme on 24th May 2017
  • FOMA meeting on 6th April 2017 at Hotel Lalit, New Delhi
  • 23rd May meeting with FOMA stakeholders regarding plan organization of Dilli Chalo Movement on 6th June 2017
  • IMA Meeting with WHO Officials on 17th June 2017
  • Meeting with President-Elect Govt. of India on 21st July 2017
  • Meeting with Dr Sanjeeva Kumar, Addl. Secretary, MoHFW on 16th August, 2017
  • Meeting Shri GP Samanta, Under Secy, GOI  to discuss the issues raised by IMA during the meeting with Hon’ble HFM on 19th September 2017 at 3.00 pm under the chairmanship of Addl. Secy. (Health) in Nirman Bhawan, New Delhi
  • Meeting with Shri Sunil Kumar Gupta, Under Secy., GOI, MoHFW, Meeting to discuss the issue raised by IMA on 27thSeptember 2017 , Nirman Bhawan, ND
  • Meeting with Dr Anil Kumar, Addl. DDG (AK) reg. Meeting of sub-committee to finalize the draft notification in respect of medical diagnostic laboratories including signatory authority/Technical head of medical diagnostic laboratory on 1st November, 2017 under the chairmanship of Dr B D Athani, Spl. DGHS Nirman Bhawan, ND
  • Shri GC Dobhal, Deputy Secretary, Petition Committee reg. Meeting of the Parliamentary Committee on petitions, Lok Sabha, w. r. t. Medical Reforms in the country on 20.11.2017 Parliament House Annexe, New Delhi

Other meetings

  • NABH Board Sub-Committee Meeting on 13th January 2017, New Delhi
  • 2nd Meeting of National Core Group on Elimination of Mother to Child Transmission (EMTC) on 6th February 2017
  • Stakeholder Consultation meeting for preparation of Concept Note (2018-20) for Global Fund Grant reg. on 13thFebruary 2017 at New Delhi.
  • NABH Board Sub-Committee Meeting on 17th February 2017, New Delhi
  • 26th Board Meeting of NABH on 24th March, 2017, New Delhi
  • 2nd Meeting of National Medical Wellness Tourism on 28th March 2017 at New Delhi
  • Meeting of Working Group Environment Health on 30th March 2017 at Indira Paryavaran Bhawan, New Delhi
  • Meeting of World Malaria Day on 25th April 2017 at New Delhi
  • Meeting regarding setting up of Facilitation Counters for visitors arriving on e-Medical Visa at International Airport on 25th April 2017 at New Delhi.
  • Meeting Of Governing Body-NBE on 28th April, 2017 New Delhi
  • Meeting of Signal Review Panel Meeting at CDSCO (PvPI) on 16th May 2017
  • Meeting of Expert Group to review self assessment report for patient safety for India & capacity development on patient safety on 30th May 2017 at New Delhi.
  • Meeting of the Expert Committee constituted to draft comprehensive FAQs related to the PC & PNDT Act, 1994 reg. on 30th May 2017 at Nirman Bhawan, New Delhi.
  • National Workshop on “Parivar Niyojan-Sashakt Samaj, Rashtra Ka Vikas on 11th  July 2017 at Vigyan Bhawan, New Delhi
  • Launch of National Strategic Plan (2017-22) by Hon’ble HFM on 12th July 2017 at 5.30 PM at Sovereign Hall, Le Meridien, New Delhi
  • Stakeholders Consultation for MTAB-Reg. on 27th July 2017 at New Delhi
  • National Board of Examination governing council meeting on 7th September, 2017, New Delhi
  • NBQP QCI 12th Nation Quality Conclave on 21-22 September, 2017
  • Inauguration of Pharmacovigilance Programme of India as a WHO collaborating centre on 30th October 2017
  • NABH Board Meeting on 3rd November, 2017
  • NBE Board Meeting on 9th November, New Delhi
  • National Steering Committee PCPNDT Act on 3rd November, 2017

International Meetings

  • Annual Scientific Meeting of Chinese Medical Association held on 14-15 January, 2016 at Nanjing (China)
  • International Summit on Air Pollution – Health Advisories held at New Delhi on March 10, 2017
  • Cyprus to attend and participate in the UNESCO Chair in Bioethics – 12th World Conference on Bioethics, Medical Ethics & Health Law to be held from March 19-24, 2017 at St. Raphael Hotel Resort & Congress Center, Limassoi, Cyprus.
  • 206th World Medical Association (WMA) Council Meeting to be held from April 15th to 22nd April, 2017 at the Avani Victoria Falls Resort in Livingstone, Zambia
  • Annual Meeting of Swedish Medical Association in Stockholm from 29th May to 31st May 2017 at Hotel Scandic Continental Vasagatan 22, Stockholm, Sweden.
  • The Annual Meeting of the American Medical Association on June 10-14, 2017 at Hyatt Regency Hotel, Chicago, Illinois, USA.
  • BMA Annual Representative Meeting on Sunday 25 June- Thursday 29 June 2017 at the Bournemouth International Centre, Exeter Road, Bournemouth BH2 5BH,
  • 32nd CMAAO General Assembly in September 13-15, 2017
  • WMA General Assembly on October 11-14, 2017 at Renaissance Downtown Hotel, Chicago
  • WMA European Region Meeting on End-of-Life Questions on November 16-17, 2017 at Vatican